The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBanco Santander Regulatory News (BNC)

Share Price Information for Banco Santander (BNC)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 383.50
Bid: 388.00
Ask: 390.00
Change: 0.00 (0.00%)
Spread: 2.00 (0.515%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 383.50
BNC Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Information on Santander Dividendo Eleccion

7 Nov 2018 07:00

RNS Number : 5548G
Banco Santander S.A.
06 November 2018
 

 

 

 

 

 

MATERIAL FACT

 

 

Further to the material fact communication dated October 16, 2018 (registry number 270,543), Banco Santander, S.A. ("Banco Santander") announces that the trading period for the bonus share rights corresponding to the capital increase with a charge to reserves (the "Capital Increase") through which the "Santander Dividendo Elección" scheme is carried out ended on November 1, 2018.

 

The holders of 76.55% of the bonus share rights have chosen to receive new shares. Thus, the definitive number of ordinary shares of 0.5 Euros of face value issued in the Capital Increase is 100,420,360, equivalent to 0.62% of the share capital, and the amount of the Capital Increase is 50,210,180 Euros. After the Capital Increase, the share capital amounts to 8,118,286,971 Euros represented by 16,236,573,942 ordinary shares of 0.5 Euros of face value each. The value of the compensation corresponding to the holders of bonus share rights who have requested new shares amounts to 432,309,649.80 Euros.

 

The shareholders holding the remaining 23.45% of the bonus share rights have accepted the irrevocable commitment to purchase bonus share rights assumed by Banco Santander. Consequently, Banco Santander has acquired 3,784,449,227 rights for a total gross consideration of 132,455,722.95 Euros. Banco Santander has waived the bonus share rights so acquired.

 

It is envisaged that the relevant authorisations for the admission to listing of the new shares in the Spanish Stock Exchanges will be granted on November 13, 2018. As a result, ordinary trading of these shares will commence in Spain on November 14[1]. The authorisation for the admission to listing of those shares will also be requested on all other stock exchanges on which Banco Santander is listed.

 

 

Boadilla del Monte (Madrid), November 6, 2018

 


[1] Estimated date. Subject to the granting of the relevant authorisations.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
UPDLFFILLFLRIIT
Date   Source Headline
18th Dec 20235:17 pmRNSDirector/PDMR Shareholding
18th Dec 20237:05 amRNSDirector/PDMR Shareholding
14th Dec 202311:05 amRNSBuyback programme: transactions 5-13 Dec
13th Dec 20234:41 pmRNSDirector/PDMR Shareholding
13th Dec 20237:02 amRNSOptional early redemption ISIN XS1951093894
11th Dec 202311:24 amRNSSREP Capital Requirements 2024
5th Dec 202311:09 amRNSBuyback programme: transactions 30 Nov – 4 Dec
30th Nov 202311:18 amRNSTotal Voting Rights
30th Nov 202311:12 amRNSBuyback programme: transactions 23-29 Nov
23rd Nov 202311:07 amRNSBuyback programme: transactions 16-22 Nov
22nd Nov 20237:08 amRNSOptional early redemption ISIN XS1692931121
17th Nov 20237:00 amRNSAT1s Contingent Convertible securities
16th Nov 20232:24 pmRNSBuyback programme: transactions 8-15 Nov
16th Nov 202311:06 amRNSBuyback programme: transactions 8-15 Nov
8th Nov 202311:06 amRNSBuyback programme: transactions 31 Oct – 7 Nov
31st Oct 202312:03 pmRNSTotal Voting Rights
31st Oct 202310:14 amRNSBuyback programme: transactions 26–30 Oct
26th Oct 202312:09 pmRNSTotal Voting Rights
26th Oct 202311:05 amRNSBuyback programme: transactions 19 Oct – 25 Oct
25th Oct 20237:00 amRNS3Q 2023 Results Report & Earnings Presentation
25th Oct 20237:00 amRNS3rd Quarter 2023 Results - Press release
19th Oct 202311:08 amRNSBuyback programme: transactions 11 Oct – 18 Oct
18th Oct 202311:11 amRNSNotice of Third Quarter 2023 Results
11th Oct 202311:27 amRNSBuyback programme: transactions 5 Oct – 10 Oct
5th Oct 202311:41 amRNSBuyback programme: transactions 28 Sep – 4 Oct
29th Sep 202311:06 amRNSTotal Voting Rights
27th Sep 20236:31 pmRNSCommencement of a program to repurchase own shares
27th Sep 20237:00 amRNSFurther re dividend approval
27th Sep 20237:00 amRNSDividend approval & buyback program implementation
19th Sep 20237:00 amRNSSantander aligns several models to its strategy
18th Sep 20235:14 pmRNSPerpetual Preferred Securities: rate replacement
31st Aug 20233:09 pmRNSTotal Voting Rights
31st Jul 20232:35 pmRNSTotal Voting Rights
28th Jul 20235:35 pmRNSStress Test Results
28th Jul 202312:56 pmRNSHalf-year Report
26th Jul 20237:00 amRNS1H2023 Results - Press release
26th Jul 20237:00 amRNS1H2023 Results Report & Earnings Presentation
19th Jul 202311:52 amRNSNotice of First Half 2023 Results
30th Jun 20233:28 pmRNSFurther re capital reduction
30th Jun 20232:23 pmRNSTotal Voting Rights
27th Jun 20236:07 pmRNSTotal Voting Rights
27th Jun 20236:03 pmRNSCapital reduction (buy-back programme shares)
31st May 202312:19 pmRNSTotal Voting Rights
19th May 202310:51 amRNSDirector/PDMR Shareholding
18th May 20235:20 pmRNSSantander informs of the MREL determined by SRB
3rd May 202311:38 amRNSCovered Bonds: interest rate replacement
28th Apr 202311:39 amRNSTotal Voting Rights
28th Apr 202311:24 amRNSDirector/PDMR Shareholding
25th Apr 20237:00 amRNS1Q2023 Financial report & Earnings presentation
25th Apr 20237:00 amRNS1Q2023 Results - Press release

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.